This page is part of the FHIR Specification (v0.0.82: DSTU 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
Drug-drug interaction between prescription and medication statement
{
"resourceType": "Contraindication",
"id": "ddi",
"text": {
"status": "generated",
"div": "<div>!-- Snipped for Brevity --></div>"
},
"category": {
"coding": [
{
"system": "http://hl7.org/fhir/v3/ActCode",
"code": "DRG",
"display": "Drug Interaction Alert"
}
]
},
"severity": "H",
"implicated": [
{
"reference": "MedicationStatement/tylenol",
"display": "500 mg Acetaminophen tablet 1/day, PRN since 2010"
},
{
"reference": "MedicationPrescription/warfarin",
"display": "Warfarin 1 MG TAB prescribed Jan. 5, 2014"
}
],
"detail": "Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.",
"date": "2014-01-05",
"author": {
"reference": "Device/dsp"
},
"mitigation": [
{
"action": {
"coding": [
{
"system": "http://hl7.org/fhir/v3/ActCode",
"code": "30",
"display": "Stopped Concurrent Therapy"
}
],
"text": "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"
},
"date": "2014-01-05",
"author": {
"reference": "Practitioner/example",
"display": "Dr. Adam Careful"
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.